This is a non-core endpoint: only basic statistics are computed.
Assault by unspecified chemical or noxious substance
VWXY20_ASSAU_UNSPE_CHEMIC_NOXIO_SUBST
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
13 |
4. Check minimum number of eventsNone |
13 |
5. Include endpointsNone |
13 |
6. Filter based on genotype QC (FinnGen only) |
13 |
Control definitions (FinnGen only)
- Control exclude
- VWXY20_ASSAULT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- X85-Y09
Similar endpoints
↥List of similar endpoints to
Assault by unspecified chemical or noxious substance
based on the number of shared cases.
Similar with more cases:
- Assault
- External causes of morbidity and mortality
- Injury, poisoning and certain other consequences of external causes
- Anti-inflammatory and antirheumatic products, non-steroids
- Paracetamol of NSAID medication
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 13 | - | 10 |
| Unadjusted period prevalence (%) | 0.00 | - | 0.00 |
| Median age at first event (years) | 35.37 | - | 34.04 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
22
3.04
1.15
1.6
1.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
6
28
3.09
1.10
2.5
2.1
u/l
2143.8
145.5
—
6
28
(3015736) pH of Urine
5
32
1.90
0.49
2.8
3.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
13
115
+∞
0.44
6.1
7.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
5
35
1.69
0.29
4.2
2.6
—
33.9
—
0
15
(3021601) Nitrite [Presence] in Urine by Test strip
5
40
1.40
0.26
3.8
4.4
—
0.0
—
0
6
(3037467) Urinalysis macro (dipstick) panel - Urine
8
65
1.59
0.25
1.8
3.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
0
11
0.00
0.22
0.0
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
0
11
0.00
0.22
0.0
2.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
0
10
0.00
0.22
0.0
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
0
10
0.00
0.22
0.0
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
0
10
0.00
0.22
0.0
1.6
—
1.1
—
0
10
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
0
10
0.00
0.22
0.0
1.3
—
1.8
—
0
5
(3025941) Bacteria identified in Stool by Culture
0
10
0.00
0.22
0.0
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
0
10
0.00
0.22
0.0
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
12
0.00
0.22
0.0
1.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
5
42
1.31
0.12
2.8
3.2
—
0.0
—
0
6
(3035350) Ketones [Presence] in Urine by Test strip
5
42
1.31
0.12
2.4
3.1
—
0.0
—
0
6
(3044889) 12 lead EKG panel
8
71
1.33
0.11
2.5
2.8
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
6
0.00
0.00
0.0
1.3
—
407.7
—
0
6
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
5
51
0.97
0.00
3.6
3.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009343) pH of Capillary blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
26.5
—
0
6
(3024980) IgG subclass 4 [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.5
—
0.5
—
0
6
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
0
6
0.00
0.00
0.0
2.0
—
209.8
—
0
6
(3000764) Benzodiazepines [Presence] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
0
5
0.00
0.00
0.0
1.4
—
157.2
—
0
5
(1761868) Lipid panel - Serum or Plasma
5
49
1.03
0.00
3.8
2.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012544) pH of Venous blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(4034850)
0
5
0.00
0.00
0.0
17.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
0
8
0.00
0.00
0.0
13.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002224) Polysomnography panel
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
0
8
0.00
0.00
0.0
1.4
—
4.5
—
0
8
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
0
5
0.00
0.00
0.0
1.0
—
5.4
—
0
5
(3028300) Cannabinoids [Presence] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.0
—
11.2
—
0
5
(3021447) Carbon dioxide [Partial pressure] in Venous blood
0
8
0.00
0.00
0.0
1.5
—
5.5
—
0
8
(3019225) pH of Specimen
0
7
0.00
0.00
0.0
4.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: VWXY20_ASSAU_UNSPE_CHEMIC_NOXIO_SUBST – Assault by unspecified chemical or noxious substance
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).